Unknown

Dataset Information

0

In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens.


ABSTRACT: The pleuromutilin antibiotic lefamulin demonstrated in vitro activity against the most relevant bacterial pathogens causing sexually transmitted infections (STI), including Chlamydia trachomatis (MIC50/90, 0.02/0.04 mg/liter; n = 15), susceptible and multidrug-resistant Mycoplasma genitalium (MIC range, 0.002 to 0.063 mg/liter; n = 6), and susceptible and resistant Neisseria gonorrhoeae (MIC50/90, 0.12/0.5 mg/liter; n = 25). The results suggest that lefamulin could be a promising first-line antibiotic for the treatment of STI, particularly in populations with high rates of resistance to standard-of-care antibiotics.

SUBMITTER: Paukner S 

PROVIDER: S-EPMC5923106 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>In Vitro</i> Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens.

Paukner Susanne S   Gruss Astrid A   Jensen Jørgen Skov JS  

Antimicrobial agents and chemotherapy 20180426 5


The pleuromutilin antibiotic lefamulin demonstrated <i>in vitro</i> activity against the most relevant bacterial pathogens causing sexually transmitted infections (STI), including <i>Chlamydia trachomatis</i> (MIC<sub>50/90</sub>, 0.02/0.04 mg/liter; <i>n</i> = 15), susceptible and multidrug-resistant <i>Mycoplasma genitalium</i> (MIC range, 0.002 to 0.063 mg/liter; <i>n</i> = 6), and susceptible and resistant <i>Neisseria gonorrhoeae</i> (MIC<sub>50/90</sub>, 0.12/0.5 mg/liter; <i>n</i> = 25).  ...[more]

Similar Datasets

| S-EPMC4514671 | biostudies-literature
2019-03-19 | GSE120192 | GEO
| S-EPMC5783918 | biostudies-literature
| S-EPMC5325242 | biostudies-other
| S-EPMC6402362 | biostudies-literature
| S-EPMC4741364 | biostudies-literature
| S-EPMC4442722 | biostudies-other
| S-EPMC8383303 | biostudies-literature
| S-EPMC8620572 | biostudies-literature
| S-EPMC6765433 | biostudies-literature